Literature DB >> 4905291

[Experiences with N-Lost phosphamide esters].

P Drings, R Allner, N Brock, H Burkert, M Fischer, E Fölsch, H Gerhartz, P Götzky, I Hoppe, G Kanzler, H O Klein, K Mainzer, H Martin, P Obrecht, G Palme, H Paulisch, H Riegg, J C Schubert, U Treske, W Weise, D Willems, H Wilmanns, S Witte, H Wohlenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4905291     DOI： 10.1055/s-0028-1108490

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN： 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  4 in total

1.  Fractionated ifosfamide therapy produces a time-dependent increase in ifosfamide metabolism.

Authors:  L D Lewis; D L Fitzgerald; P G Harper; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

2.  Phase II study of ifosfamide and mesna in patients with previously-treated carcinoma of the cervix. A Gynecologic Oncology Group study.

Authors:  G P Sutton; J A Blessing; L Adcock; K D Webster; T DeEulis
Journal:  Invest New Drugs       Date:  1989-11       Impact factor: 3.850

Review 3.  Treatment of primary intraocular lymphoma with oral trofosfamide: report of two cases and review of the literature.

Authors:  Kristoph Jahnke; Nikolaos E Bechrakis; Sarah E Coupland; Alexander Schmittel; Michael H Foerster; Lars Fischer; Eckhard Thiel; Agnieszka Korfel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09       Impact factor: 3.117

4.  Oral trofosfamide: an active drug in the treatment of soft-tissue sarcoma.

Authors:  C Blomqvist; T Wiklund; M Pajunen; M Virolainen; I Elomaa
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.